| Sex differences in immune responses SL Klein, KL Flanagan Nature Reviews Immunology 16 (10), 626-638, 2016 | 5732 | 2016 |
| Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ... Nature medicine 9 (6), 729-735, 2003 | 723 | 2003 |
| Sex and gender differences in the outcomes of vaccination over the life course KL Flanagan, AL Fink, M Plebanski, SL Klein Annual review of cell and developmental biology 33 (1), 577-599, 2017 | 533 | 2017 |
| Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis S Nyamweya, A Hegedus, A Jaye, S Rowland‐Jones, KL Flanagan, ... Reviews in medical virology 23 (4), 221-240, 2013 | 467 | 2013 |
| Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial KJ Jensen, N Larsen, S Biering-Sørensen, A Andersen, HB Eriksen, ... The Journal of infectious diseases 211 (6), 956-967, 2015 | 227 | 2015 |
| The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility R Vemuri, KE Sylvia, SL Klein, SC Forster, M Plebanski, R Eri, ... Seminars in immunopathology 41, 265-275, 2019 | 224 | 2019 |
| Potent induction of focused Th1-type cellular and humoral immune responses by RTS, S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine A Lalvani, P Moris, G Voss, AA Pathan, KE Kester, R Brookes, E Lee, ... The Journal of infectious diseases 180 (5), 1656-1664, 1999 | 219 | 1999 |
| Suboptimal SARS-CoV-2− specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype JR Habel, THO Nguyen, CE van de Sandt, JA Juno, P Chaurasia, ... Proceedings of the National Academy of Sciences 117 (39), 24384-24391, 2020 | 210 | 2020 |
| RSV prevention in all infants: which is the most preferable strategy? S Esposito, B Abu Raya, E Baraldi, K Flanagan, F Martinon Torres, ... Frontiers in immunology 13, 880368, 2022 | 175 | 2022 |
| Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines S Esposito, P Stefanelli, NK Fry, G Fedele, Q He, P Paterson, T Tan, ... Frontiers in immunology 10, 1344, 2019 | 175 | 2019 |
| Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants S Burl, J Townend, J Njie-Jobe, M Cox, UJ Adetifa, E Touray, VJ Philbin, ... PloS one 6 (4), e18185, 2011 | 159 | 2011 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 158 | 2021 |
| Interleukin 10–mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum M Plebanski, KL Flanagan, EAM Lee, WHH Reece, K Hart, C Gelder, ... Immunity 10 (6), 651-660, 1999 | 156 | 1999 |
| Identification of a human neonatal immune-metabolic network associated with bacterial infection CL Smith, P Dickinson, T Forster, M Craigon, A Ross, MR Khondoker, ... Nature communications 5 (1), 4649, 2014 | 155 | 2014 |
| Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment C Govindaraj, K Scalzo-Inguanti, M Madondo, J Hallo, K Flanagan, ... Clinical immunology 149 (1), 97-110, 2013 | 146 | 2013 |
| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ... Immunity 54 (5), 1066-1082. e5, 2021 | 139 | 2021 |
| Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming M Plebanski, EAM Lee, CM Hannan, KL Flanagan, SC Gilbert, ... Nature medicine 5 (5), 565-571, 1999 | 134 | 1999 |
| The non-specific and sex-differential effects of vaccines P Aaby, CS Benn, KL Flanagan, SL Klein, TR Kollmann, DJ Lynn, ... Nature Reviews Immunology 20 (8), 464-470, 2020 | 129 | 2020 |
| Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines KL Flanagan, E Best, NW Crawford, M Giles, A Koirala, K Macartney, ... Frontiers in immunology 11, 579250, 2020 | 124 | 2020 |
| Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses … S Burl, UJ Adetifa, M Cox, E Touray, MO Ota, A Marchant, H Whittle, ... The Journal of immunology 185 (4), 2620-2628, 2010 | 117 | 2010 |
Magdalena PlebanskiRMIT University (current)Verified email at monash.edu
